{
    "code": "01044602",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01044602",
    "time": "2016-05-20 06:34:04",
    "許可證字號": "衛署藥製字第044602號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/08\/20",
    "發證日期": "90\/08\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104460209",
    "中文品名": "拜渡帕錠２５\/２５０毫克",
    "英文品名": "BIDOPAR TABLETS 25\/250MG",
    "適應症": "帕金森氏症及綜合病徵（肌肉強直及運動遲緩、震顫、流涎、吞嚥困難及姿勢不穩）。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠塑膠瓶、鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "LEVODOPA, CARBIDOPA",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "0908703200  信東生技股份有限公司",
    "申請商地址": "桃園市桃園區介壽路２２號",
    "主製造廠": {
        "製造廠名稱": "0908703300  信東生技股份有限公司",
        "製造廠廠址": "桃園市桃園區介壽路２２號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002900",
            "成分名稱": "LEVODOPA",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2408000400",
            "成分名稱": "CARBIDOPA",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ]
}